Hemolysis in glucose-6-phosphate dehydrogenase deficiency.
D000349:Africa; D000743:Anemia, Hemolytic / Q000139:chemically induced*; D001803:Blood Transfusion; D002681:China; D002701:Chloramphenicol / Q000009:adverse effects; D005006:Ethnicity; D005236:Favism / Q000209:etiology; D005260:Female; D005796:Genes; D005954:Glucosephosphate Dehydrogenase; D005955:Glucosephosphate Dehydrogenase Deficiency / Q000150:complications* / Q000175:diagnosis / Q000235:genetics; D006461:Hemolysis; D006579:Heterozygote; D006801:Humans; D007231:Infant, Newborn; D007527:Isoenzymes; D007567:Jaundice, Neonatal / Q000453:epidemiology; D008288:Malaria / Q000517:prevention & control; D008297:Male; D008521:Mediterranean Islands; D009154:Mutation; D010597:Pharmacogenetics; D011159:Population Surveillance; D011319:Primaquine / Q000008:administration & dosage; D012730:Sex Chromosomes; D014435:Typhoid Fever / Q000188:drug therapy
D007527:Isoenzymes; D002701:Chloramphenicol; D005954:Glucosephosphate Dehydrogenase; D011319:Primaquine